相似文献
1
Proton Pump Inhibitors in Allergy: Benefits and Risks.
J Allergy Clin Immunol Pract. 2022 Dec;10(12):3117-3123. doi: 10.1016/j.jaip.2022.09.022. Epub 2022 Sep 23.
2
Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
Clin Rev Allergy Immunol. 2019 Oct;57(2):213-225. doi: 10.1007/s12016-018-8701-4.
3
Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.
Gastroenterol Clin North Am. 2014 Jun;43(2):243-56. doi: 10.1016/j.gtc.2014.02.004. Epub 2014 Mar 24.
4
The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.
Expert Rev Clin Immunol. 2016 Sep;12(9):945-52. doi: 10.1080/1744666X.2016.1178574. Epub 2016 Apr 28.
5
Associations between Proton-Pump Inhibitor Usage, Allergy, and Asthma: An Analysis of NHANES 2005-2006.
Int Arch Allergy Immunol. 2024;185(6):519-526. doi: 10.1159/000535156. Epub 2024 Mar 1.
6
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
Curr Gastroenterol Rep. 2017 Sep;19(9):46. doi: 10.1007/s11894-017-0586-5.
7
Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
J Gastroenterol. 2017 Feb;52(2):203-210. doi: 10.1007/s00535-016-1213-1. Epub 2016 Apr 23.
8
AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Gastroenterology. 2022 Apr;162(4):1334-1342. doi: 10.1053/j.gastro.2021.12.247. Epub 2022 Feb 17.
9
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE).
Dig Liver Dis. 2017 Mar;49(3):254-260. doi: 10.1016/j.dld.2016.11.012. Epub 2016 Dec 2.
10
Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
BMC Geriatr. 2020 Oct 29;20(1):431. doi: 10.1186/s12877-020-01844-w.
引用本文的文献
1
Eosinophilic esophagitis in children and adolescents: a clinical practice guideline.
Ital J Pediatr. 2025 Jul 23;51(1):242. doi: 10.1186/s13052-025-02056-x.
2
Proton pump inhibitors and risk of hearing loss; a systematic review.
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 9. doi: 10.1007/s00210-025-04241-5.
3
Antireflux mucosal valvuloplasty versus proton pump inhibitors for the treatment of patients with gastro-oesophageal reflux disease in a tertiary healthcare centre in China: study protocol for a randomised controlled trial.
BMJ Open. 2024 Dec 22;14(12):e088970. doi: 10.1136/bmjopen-2024-088970.
4
Safety of Proton Pump Inhibitors in Pediatric Population: A Systematic Review.
Glob Pediatr Health. 2024 Apr 29;11:2333794X241248967. doi: 10.1177/2333794X241248967. eCollection 2024.
本文引用的文献
1
Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.
Lupus. 2022 Aug;31(9):1078-1083. doi: 10.1177/09612033221104237. Epub 2022 May 30.
2
Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis.
Dig Liver Dis. 2022 Sep;54(9):1179-1185. doi: 10.1016/j.dld.2022.03.006. Epub 2022 Apr 8.
3
Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions.
J Asthma Allergy. 2022 Feb 26;15:281-302. doi: 10.2147/JAA.S274524. eCollection 2022.
4
Stress Ulcer Prophylaxis for Critical Asthma.
Pediatrics. 2022 Apr 1;149(4). doi: 10.1542/peds.2021-054527.
5
Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.
Indian Dermatol Online J. 2022 Jan 24;13(1):64-72. doi: 10.4103/idoj.idoj_237_21. eCollection 2022 Jan-Feb.
6
AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Gastroenterology. 2022 Apr;162(4):1334-1342. doi: 10.1053/j.gastro.2021.12.247. Epub 2022 Feb 17.
7
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes.
Eur Respir J. 2021 Dec 31;59(1). doi: 10.1183/13993003.02730-2021. Print 2022 Jan.
8
Randomised trials of proton pump inhibitors for gastro-oesophageal reflux disease in patients with asthma: an updated systematic review and meta-analysis.
BMJ Open. 2021 Aug 10;11(8):e043860. doi: 10.1136/bmjopen-2020-043860.
9
Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma.
Cochrane Database Syst Rev. 2021 May 17;5(5):CD001496. doi: 10.1002/14651858.CD001496.pub2.
10
Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine.
Drugs Real World Outcomes. 2021 Sep;8(3):325-335. doi: 10.1007/s40801-021-00234-x. Epub 2021 Apr 8.
Zotero 插件